HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus: correlations with clinical and autoantibody subsets

We conducted this study to determine the HLA class II allele associations in a large cohort of patients of homogeneous ethnic derivation with systemic lupus erythematosus (SLE). The large sample size allowed us to stratify patients according to their clinical and serologic characteristics. We studied 577 European Caucasian patients with SLE. Antinuclear antibodies (Hep-2 cells), anti-dsDNA antibodies (Crithidia luciliae), and antibodies to extractable nuclear antigens Ro (SS-A), La (SS-B), U1-RNP, Sm, Jo1, SCL70, and PCNA, were detected in all patients. Molecular typing of HLA-DRB1, DRB3, DQA1, and DQB1 loci was performed by the polymerase chain reaction-sequence specific oligonucleotide probes (PCR-SSOP) method. We found a significantly increased frequency of DRB1*03, DRB1*15, DRB1*16, DQA1*0102, DQB1*0502, DQB1*0602, DQB1*0201, DQB1*0303, and DQB1*0304 in lupus patients as compared with healthy controls. In addition, DRB1*03 was associated with anti-Ro, anti-La, pleuritis, and involvement of lung, kidney, and central nervous system. DRB1*15 and DQB1*0602 were associated with anti-dsDNA antibodies; DQB1*0201 with anti-Ro and anti-La, leukopenia, digital skin vasculitis, and pleuritis; and DQB1*0502 was associated with anti-Ro, renal involvement, discoid lupus, and livedo reticularis. In conclusion, our study shows some new HLA clinical and serologic associations in SLE and further confirms that the role of MHC genes is mainly to predispose to particular serologic and clinical manifestations of this disease

Blind-prediction: Estimating the consequences of vented hydrogen deflagrations for inhomogeneous mixtures in 20-foot ISO containers

This paper summarises the results from a blind-prediction benchmark study for models used for estimating the consequences of vented hydrogen deflagrations, as well as for users of such models. The work was part of the HySEA project that received funding from the Fuel Cells and Hydrogen Joint Undertaking (FCH JU) under grant agreement no. 671461. The first blind-prediction benchmark exercise in the HySEA project focused on vented explosions with homogeneous hydrogen-air mixtures in 20-foot ISO containers. The scenarios selected for the second blind-prediction study focused on vented deflagrations in inhomogeneous hydrogen-air mixtures resulting from continuous stratification of hydrogen during vertical jet releases inside 20-foot ISO containers. The deflagrations were vented through commercial vent panels located on the roof of the containers. The test program included two configurations and four experiments, i.e. two repeated tests for each scenario. The paper compares experimental results and model predictions and discusses the implications of the findings for safety related to hydrogen applications. Several modellers predicted the stratification of hydrogen inside the container during the release phase with reasonable accuracy. However, there is significant spread in the model predictions, especially for the maximum reduced explosion pressure, and including predictions from different modellers using the same model system. The results from the blind-prediction benchmark studies performed as part of the HySEA project constitute a strong incentive for developers of consequence models to improve their models, implement automated procedures for scenario definition and grid generation, and update training and guidelines for users of the models

Blind-prediction: Estimating the consequences of vented hydrogen deflagrations for homogeneous mixtures in 20-foot ISO containers

This paper summarises the results from a blind-prediction study for consequence models used for estimating the reduced explosion pressure and structural response in vented hydrogen deflagrations. The work is part of the project Improving hydrogen safety for energy applications through pre-normative research on vented deflagrations (HySEA). The scenarios selected for the blind-prediction entailed vented explosions with homogeneous hydrogen-air mixtures in a 20-foot ISO (International Organization for Standardization) container. The test program included two configurations and six experiments, i.e. three repeated tests for each scenario. The comparison between experimental results and model predictions reveals reasonable agreement for some of the models, and significant discrepancies for others. The results from the first blind-prediction study in the HySEA project should motivate developers to improve and validate their models, as well as to update documentation and guidelines for users of the models

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

The importance of donor-recipient human leukocyte antigen (HLA)-DPB1 matching for the clinical outcome of unrelated hematopoietic stem cell transplantation (HSCT) is controversial. We have previously described an algorithm for nonpermissive HLA-DPB1 disparities involving HLA-DPB1*0901,*1001,*1701,*0301,*1401,*4501, based on T-cell alloreactivity patterns. By revisiting the immunogenicity of HLA-DPB1*02, a modified algorithm was developed and retrospectively tested in 621 unrelated HSCTs facilitated through the Italian Registry for oncohematologic adult patients. The modified algorithm proved to be markedly more predictive of outcome than the original one, with significantly higher Kaplan-Meier probabilities of 2-year survival in permissive compared with nonpermissive transplantations (55% vs 39%, P = .005). This was the result of increased adjusted hazards of nonrelapse mortality (hazard ratio [HR] = 1.74; confidence interval [CI], 1.19-2.53; P = .004) but not of relapse (HR = 1.02; CI, 0.73-1.42; P = .92). The increase in the hazards of overall mortality by nonpermissive HLA-DPB1 disparity was similar in 10 of 10 (HR = 2.12; CI, 1.23-3.64; P = .006) and 9 of 10 allele-matched transplantations (HR = 2.21; CI, 1.28-3.80; P = .004), both in early-stage and in advanced-stage disease. These data call for revisiting current HLA matching strategies for unrelated HSCT, suggesting that searches should be directed up-front toward identification of HLA-DPB1 permissive, 10 of 10 or 9 of 10 matched donors

Lessons from the "Euro-Lupus Cohort"

The "Euro-Lupus Cohort" is composed by 1,000 patients with systemic lupus erythematosus (SLE) that have been followed prospectively since 1991. These patients have been gathered by a European consortium - the "Euro-Lupus Project Group". This consortium was originated as part of the network promoted by the "European Working Party on SLE", a working group created in 1990 in order to promote research in Europe on the different problems related to this disease. The "Euro-Lupus Cohort" provides an updated information on the SLE morbidity and mortality characteristics in the present decade as well as defines several clinical and immunological prognostic factors